2m 2m 2m 2m 2m 2m 2m
Galmed Pharmaceu (GLMD)
NASDAQ
$0.53-$0.007 (-1.27%)
Price as of Jul 13, 2026 6:30 PM EDT- $6.2MMarket Cap
- -74.32%1-Year Change
- BiotechnologyIndustry
Galmed Pharmaceu (GLMD)
$0.53-$0.007 (-1.27%)
GLMD | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $0.54 | ||
Change | -$0.02 (-4.14%) | ||
Open | $0.55 | ||
High | $0.55 | ||
Low | $0.49 | ||
Previous Close | $0.56 | ||
Volume | 67,668 | ||
30-Day Average Volume | 132,787 | ||
1-Week Change | -3.63% | ||
1-Month Change | -12.29% | ||
1-Year Change | -74.32% | ||
3-Year Change | -97.85% | ||
5-Year Change | -99.89% | ||
Fundamentals | |||
Shares Outstanding | 11.1M | ||
Total Assets | $18.6M | ||
Market Cap | $6.2M | ||
Enterprise Value | $2.2M | ||
Period: QTR TTM FY | |||
Revenue | N/A | ||
Net Income | N/A | ||
Free Cash Flow | N/A | ||
EBIT | N/A | ||
EBITDA | N/A | ||
Net Working Capital | N/A | ||
EPS | N/A | ||
Enterprise Value/EBITDA | N/A | ||
Enterprise Value/Revenue | N/A | ||
P/B | N/A | ||
P/E | N/A | ||
PEG | N/A | ||
Price/Free Cash Flow | N/A | ||
Price/Operating Cash Flow | N/A | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | 1 : 12 | ||
Last Split Date | 08/30/2024 | ||
Earnings & Revenue